Title: ANESTHESIA OVERVIEW
1BASICANESTHESIA PRACTICE
2ANESTHESIA DEFINITION
- TRADITIONAL
- LOSS OF SENSATION WITH OR WITHOUT LOSS OF
CONSCIOUSNESS
3MECHANISMS OF ACTION
- Interaction at cellular receptor site
- Action Intracellular
- Cortical depression
4PAIN
- Pain is always subjective. Each individual
learns the application of the word through
experiences related in early life.
5I.A.S.P.
- International Association for Study of Pain
6Pain
- An unpleasant sensory and emotional experience
associated with actual or potential tissue damage
or injury, or described in terms of such damage
or injury.
7ETIOLGY OF PAIN
- HEAT
- COLD
- CHEMICAL
- MECHANICAL
- TORSION STRETCH CUT PINCH PRICK
COMPRESS CRUSH
8TYPOLOGY OF PAIN
- Acute
- Chronic benign
- Chronic cancer
9Chronic Pain vs Acute Pain
- Acute A Symptom of Injury or Disease
- Chronic Benign Pain itself is the disease
- Chronic Cancer Actual Tissue destruction
10Acute Pain
- A complex constellation of unpleasant sensory,
perceptive and emotional experiences and certain
associated autonomic psychological, emotional
behavioral responses provoked by noxious
stimulation.
11CHRONIC PAIN
- PAIN THAT PERSIST BEYOND
- USUAL COURSE OF HEALING
- (3 - 6 MONTHS)
12Adverse Effects of Pain
- Cardiovascular
- Pulmonary
- Gastrointestinal
- Renal
- Extremities
- Endocrine
- CNS
- Immunologic
13Adverse Effects of Pain
- Cardiovascular Tachycardia, hypertension,
increased SVR, increased cardiac work, increased
myocardial O2 demand. - Pulmonary Hypoxia, hypercarbia, atelectasis,
decreased cough, decreased vital capacity and
function residual capacity, V/Q mismatch. - Gastrointestinal Nausea, vomiting, ileus,
intolerance for oral intake. - Renal Oliguria, urinary retention.
14Adverse Effects of Pain
- Extremities Skeletal muscle spasm, limited
mobility, thromboembolism. - Endocrine Excessive adrenergic activity, vagal
inhibition, catabolic metabolism, increased O2
consumption. - CNS Sedation, fatigue, anxiety, and fear cause
central sympathetic stimulation. - Immunologic Inhibited cellular immunity,
increased risk of infection, ?? impaired wound
healing ??
15FREE NERVE ENDINGS ARE PRESENT IN ESSENTIALLY ALL
BODY TISSUES IN VARYING AMOUNTS
16IN RESPONSE TO A PAINFUL STIMULUS, SUBSTANCES ARE
EXCRETED.
17ALGOGENIC(substances released by pain)
- SEROTONIN POTASSIUM
- HISTAMINE ACETLYCHOLINE
- BRADYKININS LEUKOTRIENES
- PROSTAGLANDINS SUBSTANCE P29
- NOREPINEPHRINE
18THE RECEPTORS IN THE FREE NERVE ENDINGS RESPOND
TO THE SUBSTANCES BY BECOMING CHARGED
ELECTROCHEMICALY
19RECEPTORS THEN PROPAGATE AN ELECTROCHEMICAL
STIMULUS TO DIFFERING NERVE FIBERS
20NOCICEPTION
- This electrochemical event that occurs
between the site of tissue damage or injury sets
off a series of neural transmissions that
eventually results in the perception of
painCollectively this known as nociception
21NERVE FIBERPAIN CLASSIFICATION
- A FIBER..SHARP-STABBING-LOCAL
- FIRST PAIN
- B FIBER....PHYSIOLOGIAL REACTION
- C FIBER....DULL-ACHE-BURN-THROB
- NONLOCALIZED-RADIATE
- SECOND PAIN
22NERVE FIBER CLASSIFCATION
- TYPE FUNCTION
- A a myelinated motor
- A alpha myelinated touch-pressure
- A beta myelinated touch-pressure
- A delta myelinated pain-temperature
- A gamma myelinated proprioception
23A Delta
- 1 - 4 micrometers diameter
- Myelinated, Rapid conduction
- Sharp, localized
- Heat, cold
- First pain
24NERVE FIBER CLASSIFCATION
- TYPE FUNCTION
-
- B myelinated preganglionic autonomic
- C non-myelinated pain-temperature
25C Fibers
- Small
- Slow Conduction
- Unmyelinated
- Postganglionic autonomic
26C Fibers
- Dull pain, burning, Aching throbbing
- Nonlocalized - radiating - diffused
- Temperature,Touch,Mechanical
- Second pain
27Gate Theory
- Balance between A delta and C fibers to dorsal
horn determines the intensity of the stimulus
that is passed to higher brain center
28Area of High Nociceptor Concentration
- Mucosal membranes
- Periosteum
- Deep fascia
- Ligaments
- Joint capsules
- Cornea
- Subcutaneous tissue
29Areas of Moderate Nociceptor Concentration
- Skeletal muscle
- Cardiac muscle
- Smooth muscle
30Areas of Minimal Nociceptor Concentration
31Physiologic Processes of Nociception
- Detection
- Transduction
- Transmission
- Modulation
- Perception
32Detection
33TRANSDUCTION
- NOXIOUS STIMULI TRANSLATED INTO ELECTRICAL FIRING
AT THE SENSORY NERVE ENDINGS
34TRANSMISSION
- PROPAGATION OF IMPULSE TRAVELS VIA NEURAL
PATHWAYS. - SENSORY AFFERENT NEURONS PROJECT INTO THE
SPINAL CORD - ASCENDING NEURONS RELAY TO BRAINSTEM AND THALAMUS
- THALAMUS RELAYS TO CEREBRAL CORTEX
35MODULATION
- INTRINIC PAIN MODIFICATION
- 1.DIFFERENT IN INDIVIDUALS
- 2.DEPENDS ON.....
- PAST EXPERIENCES
- CULTURE
- PSYCHIC
36MODULATION-CONT
- STIMULUS PRODUCED ANALGESIA
- NEUROENDOCRINE ANALGESIA
- CNS/PNS ANALGESIA
- OPIOID ANALGESIA
- SITUATION
- PATHOLOGY
- PHYSIOLOGY
37Modulation Excitatory Substances
- Peripheral
- Prostaglandins, bradykinins, histamine, K,
substance P, serotonin (5HT2) - Spinal
- Glutamate, aspartate, amino acids, substance P,
norepinephrine (alpha 1)
38Modulation - Inhibitory
- Supraspinal
- Endorphins, enkephalins, dynorphins,
norepinephrine (alpha 2), GABA, somatostatin
(5HT1), neurotensin
39First Neuron Pain
- Peripheral afferent fibers to dorsal horn
- Second Neuron Pain
- Dorsal horn to thalamic
- Third Neuron Pain
- Thalamus to cortex
40IDEAL ANESTHETIC
- 1. SEDATION - HYPNOSIS
- 2. AMNESIA
- 3. ANALGESIA
- 4. MUSCLE RELAXATION
- 5. OBTUND REFLEXES
- 6. PHYSIOLOGICAL STABILITY
- 7. REVERSIBLE
- 8. ANTIEMETIC
41IDEAL COMPONENTS
- Block SENSORY feeling
- Immobilize MOTOR responses
- Obtund REFLEXES
- wipe out MEMORY
- Control VC and CTZ
- Not permanent
- Cause sense of well-being
42DELIVERY METHODS
- 1. REGIONAL ( conduction)
- 2. INTRAVENOUS (systemic)
- 3. INHALATION (ventilatory)
43REGIONAL ANESTHESIA
- SEGMENTAL LOSS OF SENSATION
- BY BLOCKING NERVE CONDUCTION
44REGIONAL
- 1. SPINAL
- 2. EPIDURAL
- 4. INTRAVENOUS ( BIER )
- 5. AXILLARY (INFILTRATION)
- 6. RETROBULBAR
45REGIONAL
- PAIN RELIEF
- DIAGNOSTIC
- THERAPEUTIC
46LOCAL ANESTHETICS
- AMIDES MAX / DOSE
- BUPIVACAINE 2 MG/KG
- LIDOCAINE 7 MG/KG
- ROPIVACAINE 4 MG/KG
- MEPIVACAINE 7 MG/KG
- PRILOCAINE 6MG/KG
47LOCAL ANESTHETICS
- ESTERS MAX /DOSE
- CHLOROPROCAINE 20 MG/KG
- COCAINE 3 MG/KG
- NOVOCAINE 12 MG/KG
- TETRACAINE 3 MG/KG
48REGIONAL ADDITIVES
- MUSCLE RELAXANTS
- NARCOTICS
- NON-STEROIDAL ANALGESICS
49GENERAL ANESTHESIA INDUCTION AGENTS
- INHALATION GASES
- INTRAVENOUS AGENTS BARBITURATES
- OPIOIDS
- BENZODIAZEPINES
- DIISOPROPYLPHENOL
- IMIDAZOLE
50INHALATION AGENTS
- NITROUS OXIDE
- HALOTHANE
- ETHRANE
- FORANE
- SUPRANE
- ULTANE
51MAC
- MINIMUM ALVELOAR CONCENTREATION
- 50 of the population will be
anesthetized...and wont move upon skin
incision...or wont jump with a clamp on their
tail!!!!!!!!!!!
52MAC
- MAC- INDUCTION
- MAC - INTUBATION
- MAC - INCISION
- MAC- MAINTENANCE
- MAC - AMNESIA
- MAC-BAR
- MAC-AWAKE
53UPTAKE AND DISTRIBUTIONBloodGas Coefficient
SolubilityHigher Concentration to Lower
54 INTRAVENOUS AGENTS
- DISSOCIATIVE DRUGS
- BARBITUATES
- DIISOPROPYLPHENOL
- IMIDAZOLE
- TRANQUILZERS
- NARCOTICS
- NEUROLEPTICS (4 5 COMBINED)
55DISSOCIATIVE
- KETAMINE ARYLCYCLOHEXYLAMINE
- LSD
- PHENCYCLIDINE
56BARBITURATES
- THIOPENTHAL - PENTOTHAL
- METHOHEXITAL - BREVITAL
57DIISOPROPYLPHENOL
58IMIDAZOLE
59BENZODIAZEPINES(TRANQUILIZERS)
- ATIVAN - LORAZEPAM
- VERSED - MIDAZOPAM
- VALIUM - DIAZEPAM
- VISTARIL - HYDROXYZINE
60Benzodiazepines
- Sedation
- Anxiolytic - anti anxiety
- Anticonvulsant
- Indirect muscle relaxation
- GABA
- Amnesia
- (No analgesia)
61Benzodiazepines Adverse Effects
- CNS
- Increased sedation, ataxia,confusion, dizziness
- Paradoxical excitation
- ?age extremes, agitation, anxiety, hallucinations
- Respiratory depression
62Benzodiazepines Adverse Effects
- Cardiovascular - ?P, ?BP
- Propylene glycol - rapid IV push
- Constipation
- Blurred vision
- Hiccups
63Benzodiazepine Reversal
- Romazicon - 0.2 mg up to 1 mg every 1 min.
- Withdrawal - seizures
64OPIOIDS
- MORPHINE
- DEMEROL
- FENTANYL
- SUFENTA
- ALFENTANIL
- REMIFENTANIL
- NON-STEROIDALS (TORADOL)
65Opiate Receptor Functions
- ? (mu) Supraspinal analgesia ??
- Respiratory depression ??
- Euphoria ,Physical dependence
- ??(kappa) Analgesia, Sedation
- ??(sigma) Dysphoria,Hallucinations
- ??(delta) Unknown
- ??(epsilon) Unknown
66Classification of Opioid Agonists and
Antagonists
- Agonists Agonist-Antagonists Antagonis
ts - Morphine Talwin Narcan
- Demerol Stadol
Naltrexone - Sufenta Nubain
- Alfenta
- Codeine
- Fentanyl
- Remifentanil
67Opioid Adverse Effects
- Cardiovascular
- Respiratory
- GI
- GU
68NEUROLEPTIC
- COMBINATION OF
NARCOTIC AND TRANQUILIZER - ORIGINALLY..LYTIC COCKTAIL
- 2nd GENERATION...INNOVAR
- 3rd.GENERATION....PROPOFOL ..NARCOTIC..VERSED
69ANTIEMETIC
- H1 BLOCKERS
- PHENOTHIAZINES
- BUTYROPHENONES
- H2 BLOCKERS
- 5-HT ANTAGONIST
- ONDANSETRON-ZOFRAN
- GRANISETRON KYTRIL DOLISETRON -
ANZEMET
70AMNESTICS
- SCOPALOMINE
- PROPOFOL
- VERSED
- NITROUS OXIDE
71MUSCLE RELAXANTS
- DEPOLORIZER (SHORT -ACTING)
- SUCCINYLCHOLINE
- NON-DEPOLORIZER (LONG - ACTING)
- MIVACURIUM CURARINE ROCURONIUM
RAPALON - PANCURONIUM VECURONIUM
- ATRACURIUM
-
72REVERSALS
- NARCOTIC
- NARCAN
- BENZODIAZAMINE
- ROMAZICON
- MUSCLE RELAXANTS
- PYRIDOSTIGMINE
- PROSTIGMIN EDROPHONIUM
- PHYSOSTIGMINE
73T.I.V.A.
- TOTAL INTRAVENOUS ANESTHESIA
- INDUCTION AGENT
- TRANQUILER
- AMNESTIC
- ANALGESIC
- MUSCLE RELAXANT
74BALANCED
75PHASES OF ANESTHESIA
- INDUCTION
- MAINTENANCE
- EMERGENCE
76INDUCTION
- ANS
- SYMPATHETIC
- PARASYMPATHETIC
- CARDIOVASCULAR
- BLOOD PRESSURE
- BLOOD VOLUME
77BLOOD VOLUME
- ESTIMATING ALLOWABLE BLOOD LOSS (EABL)
- EABL (HCTs -HCTa ) X EBV
- HCTs
- s starting
- a allowed
78Estimated Blood Volume
- PREMATURE 100
- INFANT 90
- CHILD 80
- MEN 70
- WOMEN 60
- IDEAL WEIGHTht. in cm-100kg
- 5 ft.100 5
per in. F - 5 ft.100 7
per in. M
79OBESE CALCULATION
- IDE AL WEIGHT
- 5FT.100
- FEMALE 1 in 5
- MALE 1 in 7.5
- ?????OBESE WT. ADD TO IDEAL
- WEIGHT
80INDUCTION
- POSITION CHANGES
- PULSE RATE
- ARRYTHMIAS
- RENAL -1 CC/KG/HR
- TEMPERATURE
- ACID/BASE BALANCE
- RESPIRATORY
81RESPIRATION CALCULATIONS
- RESPIRATORY
- Vd Vt POX RMV
-
- ETCO2
- PCO2 desired X RMVhavePCO2 perfect
- PCO2 got RMVwant
-
-
-
82FLUID MANAGEMENT
- FLUID THERAPY
- a) CRYSTALLOID
- b) COLLOID
- FLUID THERAPY
- a)NPO
- b) MAINTENANCE
- c) 3rd. SPACE LOSSES
- d) EBL 31 or 11
83EPINEPHRINE DILUTION
- A)1200,000 5 mcg/ml0.15 ml of 11000 in
- 30 ccs of solution
- B)1100,00010 mcg/ml0.30 ml of 11000 in
- 30 ccs of solution
- C)1300,000 3 mcg/ml0.1 ml of 11000 in
- 30 ccs of solution
84EPINEPHRINE
- CHILDREN.......10 MCG/KG
- ADULTS...
- HALOTHANE 1 MCG/KG
- ENFLURANE 3 MCG/KG
- DESFLURANE ? MCG/KG
- SEVOFLURANE ? MCG/KG
85MONITORED ANESTHESIA CARE
- HISTORY/ PHYSICAL REQUIRED
- USUAL STANDARDS OF CARE
- COST OF SERVICE
- ALTERNATIVE CASE PLAN
- USUALLY THE SICKEST
86MONITORED ANESTHESIA CARE
- SEDATION-HYNOSIS
- ANALGESIA
- AMNESIA
- PHYSIOLOGICAL STABILITY
- REVERSIBLE
- http//www2.kumc.edu/instruction/sah/NurseAnesthes
ia/nura833/conscious.htm
87SIGNS - STAGES
- ANALGESIA
- EXCITEMENT
- SURGICAL
- MEDULLARY DEPRESSION
88KEY TERMS
- SECOND GAS EFFECT
- DIFFUSION HYPOXIA
- VENTILATORY RESPONSE TO CO2
- HYPOXIA PULMONARY VASOCONSTRICTION
- PROTEIN BINDING
- IONIZATION
- PRETREATMENT - PRIMINING
89PREANESTHETIC VISIT
- Patient education
- History physical
- Surgeons or patient choice
- Informed consent
- Care Plan development
90PREANESTHETIC WORK-UP
- REVIEW
- CHART
- LAB VALUES
- EKG
- X-RAYS
91PREANESTHETIC WORK-UP
- SYSTEMS REVIEW
- NEURO-MUSCULAR STATUS
- AIRWAY
- CARDIOPULMONARY
- RENAL
- ENDOCINE
- GASTROINTESTINAL
- ALLERGIES
- DRUG HISTORY
92History and Physical
- AIRWAYspecial needs
- SUBSTANCE ABUSEwithdrawal
- DIABETEStight control
- REFLUX..pretreat
- CARDIOVASCULARGoldman
- pretreatment need, blood dyscrasia
93History and Physical
- Malignant Hyperthermia
- Myo-neural problems
- Renal
- Liver.Enzymes??..metabolism
- Gastrointestinalelectrolytes
- Endocrinethyroid, steroids
- Herbal intake
94History and Physical
- Electrocardiogram
- Atrial fib-flutter
- 1-2-3 Block
- AV disassociation
- PVCs-PACs
- ST segmentischemia
- QT Interval
- Tall p.deep q
- W.P.W
95ANESTHESIA CARE PLAN
96INFORMED CONSENT